Skip to main content
. Author manuscript; available in PMC: 2024 Jul 5.
Published in final edited form as: Eur J Med Chem. 2023 Apr 21;255:115351. doi: 10.1016/j.ejmech.2023.115351

Table 7.

Antitubercular Activity of Compound 62 Against Susceptible, MDR, and XDR Strains of Mtb

Strain/phenotype Mtb MIC (μg/mL)
V4207/
DSa
V2475/
MDRb
KZN494/
MDRb
R506/
XDRc
TF274/
XDRc
62 0.0039 0.0625 0.0156–0.0313 0.0313 0.0039
Isoniazid 0.04 16 16 8 8
Rifampin 0.0625 4 128 >128 >128
Levofloxacin 0.125 NT NT 2 1
Ofloxacin 0.5 0.5 0.5 4 8
Kanamycin 2 2 2 >128 >128
a

Drug susceptible strain of Mtb.

b

Multidrug resistant strain of Mtb.

c

Extensively drug resistant strain of Mtb.

d

The lowest concentration of the drug leads to at least a 90% reduction of bacterial growth signal by microplate Alamar Blue assay (MABA); reported MIC values are an average of three individual measurements.